시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
폐암 수술 시장 규모, 점유율, 성장 분석 : 디바이스 유형별, 최종사용자별, 지역별 - 산업 예측(2024-2031년)
Lung Cancer Surgery Market Size, Share, Growth Analysis, By Device Type (Surgical instruments, Monitoring & Visualizing Systems), By Type (Thoracotomy, Minimally Invasive Surgeries), By End-User, By Region - Industry Forecast 2024-2031
상품코드 : 1619115
리서치사 : SkyQuest
발행일 : 2024년 12월
페이지 정보 : 영문 157 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,652,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,951,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,250,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 폐암 수술 시장 규모는 2022년에 56억 달러로 평가되며, 2023년 59억 달러에서 2031년에는 81억 달러로 성장하며, 예측 기간(2024-2031년)의 CAGR은 4.1%로 성장할 전망입니다.

세계 시장 세분화 시장은 폐암과 관련된 높은 유병률과 사망률에 의해 주도되는 의료 산업의 역동적인 부문입니다. 최근 수술 기법 및 기술의 발전, 특히 비디오 보조 흉부 수술(VATS) 및 로봇 보조 수술과 같은 최소 침습 수술은 통증 감소 및 회복 시간 단축 등 환자의 예후를 개선하는 데 기여하고 있습니다. 주요 시장 성장 촉진요인으로는 폐암 발병률 증가, 조기 발견에 대한 인식 증가, 고령화 등을 들 수 있습니다. 이러한 발전에도 불구하고 치료비 상승과 개발도상국에서의 접근성 격차 등의 과제는 여전히 남아 있습니다. 의료기기 제조업체, 병원, 연구기관 간의 지속적인 연구 노력과 협력은 이러한 장애물을 극복하고 전 세계에서 폐암 수술의 이용 가능성과 효능을 향상시키는 것을 목표로 하고 있습니다.

목차

서론

조사 방법

개요

시장 역학과 전망

주요 시장 인사이트

폐암 수술 시장 규모 : 디바이스 유형별 & CAGR(2024-2031년)

폐암 수술 시장 규모 : 유형별 & CAGR(2024-2031년)

폐암 수술 시장 규모 : 최종사용자별 & CAGR(2024-2031년)

폐암 수술 시장 규모 & CAGR(2024-2031년)

경쟁 정보

주요 기업 개요

결론과 권장사항

KSA
영문 목차

영문목차

Global Lung Cancer Surgery Market size was valued at USD 5.6 billion in 2022 and is poised to grow from USD 5.9 billion in 2023 to USD 8.1 billion by 2031, growing at a CAGR of 4.1% during the forecast period (2024-2031).

The global Lung Cancer Surgery market is a dynamic segment of the healthcare industry, driven by the high prevalence and mortality associated with lung cancer. Recent advancements in surgical techniques and technologies, particularly minimally invasive procedures like video-assisted thoracic surgery (VATS) and robotic-assisted surgery, have led to improved patient outcomes, including reduced pain and shorter recovery times. Key market growth drivers include the rising incidence of lung cancer, heightened awareness for early detection, and an aging population. Despite these advancements, challenges such as high treatment costs and access disparities in developing regions persist. Ongoing research efforts and collaborations among medical device manufacturers, hospitals, and research institutions aim to overcome these obstacles, enhancing the availability and effectiveness of lung cancer surgeries globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lung Cancer Surgery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Lung Cancer Surgery Market Segmental Analysis

Global Lung Cancer Surgery Market is segmented by Device Type, Type, End-User and Region. Based on Device Type, the market is segmented into Surgical instruments, Monitoring & Visualizing Systems, Endosurgical Equipment. Based on Type, the market is segmented into Thoracotomy, Minimally Invasive Surgeries. Based on End-User, the market is segmented into Hospitals, Ambulatory Surgery Centres. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Lung Cancer Surgery Market

The global lung cancer surgery market is significantly driven by the rising prevalence of lung cancer, recognized as the leading cause of cancer-related deaths among both men and women worldwide. This alarming trend is largely attributed to the tobacco epidemic, particularly in developing countries, where the rates of lung cancer incidence and mortality are sharply increasing. The profound impact of lung cancer extends beyond physical health, profoundly affecting patients and their families, and it is increasingly regarded as a critical global health challenge. Lung cancer itself is characterized by the uncontrolled growth of lung cell tissues, necessitating effective surgical interventions for treatment.

Restraints in the Global Lung Cancer Surgery Market

The global lung cancer surgery market faces several restraints that may hinder its growth. One significant factor is the high cost associated with the surgical procedures, which can deter patients and healthcare providers from pursuing necessary treatments. Additionally, technical limitations present in certain countries further restrict the availability of advanced surgical options. Prolonged lead times required for obtaining international qualifications can complicate market entry and expansion efforts. Furthermore, the fierce competition within the medical technology sector adds another layer of challenge, potentially stifling innovation and limiting the overall progress of the lung cancer surgery market.

Market Trends of the Global Lung Cancer Surgery Market

The Global Lung Cancer Surgery market is experiencing a significant trend towards increased research and development, aimed at enhancing treatment modalities and surgical techniques. Ongoing clinical trials are pivotal in evaluating the effectiveness and safety of innovative approaches, such as targeted therapies, immunotherapies, and minimally invasive procedures. This trend is driven by the rising incidence of lung cancer globally, leading to a surge in demand for advanced surgical interventions. As pharmaceutical and medical device companies invest heavily in R&D, the market anticipates a wave of breakthroughs, ultimately improving patient outcomes and transforming standard practices in lung cancer treatment.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Lung Cancer Surgery Market Size by Device Type & CAGR (2024-2031)

Global Lung Cancer Surgery Market Size by Type & CAGR (2024-2031)

Global Lung Cancer Surgery Market Size by End-User & CAGR (2024-2031)

Global Lung Cancer Surgery Market Size & CAGR (2024-2031)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendation

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기